Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Method development for comprehensive extraction and analysis of marine toxins: Liquid-liquid extraction and tandem liquid chromatography separations coupled to electrospray tandem mass spectrometry.

Wunschel DS, Valenzuela BR, Kaiser BLD, Victry K, Woodruff D.

Talanta. 2018 Sep 1;187:302-307. doi: 10.1016/j.talanta.2018.05.019. Epub 2018 May 9.

PMID:
29853051
2.

Detection of Inorganic Salt-Based Homemade Explosives (HME) by Atmospheric Flow Tube-Mass Spectrometry.

Ewing RG, Valenzuela BR, Atkinson DA, Wilcox Freeburg ED.

Anal Chem. 2018 Jul 3;90(13):8086-8092. doi: 10.1021/acs.analchem.8b01261. Epub 2018 Jun 14.

PMID:
29851472
3.

Selective Reagent Ions for the Direct Vapor Detection of Organophosphorus Compounds Below Parts-per-Trillion Levels.

Ewing RG, Valenzuela BR.

Anal Chem. 2018 Jun 19;90(12):7583-7590. doi: 10.1021/acs.analchem.8b01265. Epub 2018 Jun 6.

PMID:
29812936
4.

Manual para la Estandarización de Estudios Clínicos en Chile: Desde la concepción hasta la publicación.

Valenzuela B MT, Urquidi B C.

Rev Chilena Infectol. 2018;35(1):91-94. doi: 10.4067/s0716-10182018000100091. Spanish. No abstract available.

5.

Transitory microbial habitat in the hyperarid Atacama Desert.

Schulze-Makuch D, Wagner D, Kounaves SP, Mangelsdorf K, Devine KG, de Vera JP, Schmitt-Kopplin P, Grossart HP, Parro V, Kaupenjohann M, Galy A, Schneider B, Airo A, Frösler J, Davila AF, Arens FL, Cáceres L, Cornejo FS, Carrizo D, Dartnell L, DiRuggiero J, Flury M, Ganzert L, Gessner MO, Grathwohl P, Guan L, Heinz J, Hess M, Keppler F, Maus D, McKay CP, Meckenstock RU, Montgomery W, Oberlin EA, Probst AJ, Sáenz JS, Sattler T, Schirmack J, Sephton MA, Schloter M, Uhl J, Valenzuela B, Vestergaard G, Wörmer L, Zamorano P.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2670-2675. doi: 10.1073/pnas.1714341115. Epub 2018 Feb 26.

6.

Alpinone exhibited immunomodulatory and antiviral activities in Atlantic salmon.

Valenzuela B, Rodríguez FE, Modak B, Imarai M.

Fish Shellfish Immunol. 2018 Mar;74:76-83. doi: 10.1016/j.fsi.2017.12.043. Epub 2017 Dec 29.

PMID:
29292197
7.

A Hybrid Constant and Oscillatory Field Ion Mobility Analyzer Using Structures for Lossless Ion Manipulations.

Prabhakaran A, Hamid AM, Garimella SVB, Valenzuela BR, Ewing RG, Ibrahim YM, Smith RD.

J Am Soc Mass Spectrom. 2018 Feb;29(2):342-351. doi: 10.1007/s13361-017-1841-6. Epub 2017 Dec 12.

PMID:
29235041
8.

Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.

Sureda M, Rebollo J, Martínez-Navarro EM, Fernández-Morejón FJ, Farré J, Muñoz V, Bretcha-Boix P, Duarte M, Manzano RG, Crespo A, Del Carmen Redal M, Valenzuela B, Brugarolas A.

Clin Transl Oncol. 2018 Jun;20(6):785-793. doi: 10.1007/s12094-017-1789-9. Epub 2017 Nov 20.

PMID:
29159791
9.

Obtainment and evaluation of adjuvant effect of the aromatic geranyl derivative Filifolinone in bacterin of Piscirickettsia salmonis.

Parra M, Valenzuela B, Imarai M, Modak B.

J Fish Dis. 2018 Jan;41(1):157-159. doi: 10.1111/jfd.12669. Epub 2017 Jul 24. No abstract available.

PMID:
28736920
10.

β-1,3/1,6-Glucan-supplemented diets antagonize immune inhibitory effects of hypoxia and enhance the immune response to a model vaccine.

Rodríguez FE, Valenzuela B, Farías A, Sandino AM, Imarai M.

Fish Shellfish Immunol. 2016 Dec;59:36-45. doi: 10.1016/j.fsi.2016.10.020. Epub 2016 Oct 11.

PMID:
27742589
11.

Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies.

Calvo E, Walko C, Dees EC, Valenzuela B.

Am Soc Clin Oncol Educ Book. 2016;35:e175-84. doi: 10.14694/EDBK_159061. Review.

12.

Isolation and Characterization of Salmonid CD4+ T Cells.

Maisey K, Montero R, Corripio-Miyar Y, Toro-Ascuy D, Valenzuela B, Reyes-Cerpa S, Sandino AM, Zou J, Wang T, Secombes CJ, Imarai M.

J Immunol. 2016 May 15;196(10):4150-63. doi: 10.4049/jimmunol.1500439. Epub 2016 Apr 6.

13.

Key cytokines of adaptive immunity are differentially induced in rainbow trout kidney by a group of structurally related geranyl aromatic derivatives.

Valenzuela B, Obreque J, Soto-Aguilera S, Maisey K, Imarai M, Modak B.

Fish Shellfish Immunol. 2016 Feb;49:45-53. doi: 10.1016/j.fsi.2015.12.008. Epub 2015 Dec 13.

PMID:
26690664
14.

Mechanisms of long-term weight regain in patients undergoing sleeve gastrectomy.

Alvarez V, Carrasco F, Cuevas A, Valenzuela B, Muñoz G, Ghiardo D, Burr M, Lehmann Y, Leiva MJ, Berry M, Maluenda F.

Nutrition. 2016 Mar;32(3):303-8. doi: 10.1016/j.nut.2015.08.023. Epub 2015 Sep 25.

PMID:
26611808
15.

Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin.

Pérez-Ruixo C, Valenzuela B, Peris JE, Bretcha-Boix P, Escudero-Ortiz V, Farré-Alegre J, Pérez-Ruixo JJ.

AAPS J. 2016 Jan;18(1):239-50. doi: 10.1208/s12248-015-9839-0. Epub 2015 Nov 17.

16.

Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits.

Campos S, Monteiro J, Valenzuela B, Gonçalinho H, de Pinho PG, Fresco P, Félix L, Antunes L.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):421-31. doi: 10.1111/bcpt.12521. Epub 2015 Dec 28.

17.

Population pharmacokinetics of kahalalide F in advanced cancer patients.

Miguel-Lillo B, Valenzuela B, Peris-Ribera JE, Soto-Matos A, Pérez-Ruixo JJ.

Cancer Chemother Pharmacol. 2015 Aug;76(2):365-74. doi: 10.1007/s00280-015-2800-1. Epub 2015 Jun 21.

PMID:
26093949
18.

Ribavirin stimulates the immune response of Atlantic salmon.

Rivas-Aravena A, Guajardo S, Valenzuela B, Cartagena J, Imarai MI, Spencer E, Sandino AM.

Vet Immunol Immunopathol. 2015 Mar 15;164(1-2):93-100. doi: 10.1016/j.vetimm.2015.01.001. Epub 2015 Jan 12.

PMID:
25631788
19.

Neuroendocrine mechanisms for immune system regulation during stress in fish.

Nardocci G, Navarro C, Cortés PP, Imarai M, Montoya M, Valenzuela B, Jara P, Acuña-Castillo C, Fernández R.

Fish Shellfish Immunol. 2014 Oct;40(2):531-8. doi: 10.1016/j.fsi.2014.08.001. Epub 2014 Aug 11. Review.

PMID:
25123831
20.

Development and validation of an HPLC-UV method for pazopanib quantification in human plasma and application to patients with cancer in routine clinical practice.

Escudero-Ortiz V, Pérez-Ruixo JJ, Valenzuela B.

Ther Drug Monit. 2015 Apr;37(2):172-9. doi: 10.1097/FTD.0000000000000121.

PMID:
25072946
21.

[Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia].

Escudero-Ortiz V, Duart-Duart MJ, Pérez-Ruixo C, Pérez-Ruixo JJ, Valenzuela B.

Farm Hosp. 2014 May 1;38(3):154-61. doi: 10.7399/fh.2014.38.3.1170. Spanish.

22.

Alpha linolenic acid (ALA) from Rosa canina, sacha inchi and chia oils may increase ALA accretion and its conversion into n-3 LCPUFA in diverse tissues of the rat.

Valenzuela B R, Barrera R C, González-Astorga M, Sanhueza C J, Valenzuela B A.

Food Funct. 2014 Jul 25;5(7):1564-72. doi: 10.1039/c3fo60688k.

PMID:
24855655
23.

Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients.

Pérez-Ruixo C, Peris JE, Escudero-Ortiz V, Bretcha-Boix P, Farré-Alegre J, Pérez-Ruixo JJ, Valenzuela B.

Cancer Chemother Pharmacol. 2014 May;73(5):1009-20. doi: 10.1007/s00280-014-2436-6. Epub 2014 Mar 25.

PMID:
24663502
24.

Development and validation of an HPLC-UV method for sorafenib quantification in human plasma and application to patients with cancer in routine clinical practice.

Escudero-Ortiz V, Pérez-Ruixo JJ, Valenzuela B.

Ther Drug Monit. 2014 Jun;36(3):317-25. doi: 10.1097/FTD.0000000000000027.

PMID:
24365980
25.

Immunomodulatory effects of the aromatic geranyl derivative filifolinone tested by the induction of cytokine expression.

Valenzuela B, Imarai M, Torres R, Modak B.

Dev Comp Immunol. 2013 Dec;41(4):675-82. doi: 10.1016/j.dci.2013.08.001. Epub 2013 Aug 13.

PMID:
23948148
26.

Development and validation of a high-performance liquid chromatography ultraviolet method for lapatinib quantification in human plasma.

Escudero-Ortiz V, Pérez-Ruixo JJ, Valenzuela B.

Ther Drug Monit. 2013 Dec;35(6):796-802. doi: 10.1097/FTD.0b013e3182959080.

PMID:
23942544
27.

Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin.

Pérez-Ruixo C, Valenzuela B, Peris JE, Bretcha-Boix P, Escudero-Ortiz V, Farré-Alegre J, Pérez-Ruixo JJ.

Clin Pharmacokinet. 2013 Dec;52(12):1111-25. doi: 10.1007/s40262-013-0092-3.

PMID:
23828617
28.

Simultaneous online SPE-HPLC-MS/MS analysis of docetaxel, temsirolimus and sirolimus in whole blood and human plasma.

Navarrete A, Martínez-Alcázar MP, Durán I, Calvo E, Valenzuela B, Barbas C, García A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 15;921-922:35-42. doi: 10.1016/j.jchromb.2013.01.017. Epub 2013 Jan 28.

PMID:
23422405
29.

Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery.

Pérez-Ruixo C, Valenzuela B, Peris JE, Bretcha-Boix P, Escudero-Ortiz V, Farré-Alegre J, Pérez-Ruixo JJ.

Cancer Chemother Pharmacol. 2013 Mar;71(3):693-704. doi: 10.1007/s00280-012-2060-2. Epub 2012 Dec 30.

PMID:
23274396
30.

Population pharmacokinetic-pharmacodynamic analysis of neutropenia in cancer patients receiving PM00104 (Zalypsis(®)).

González-Sales M, Valenzuela B, Pérez-Ruixo C, Fernández Teruel C, Miguel-Lillo B, Soto-Matos A, Pérez-Ruixo JJ.

Clin Pharmacokinet. 2012 Nov;51(11):751-64. doi: 10.1007/s40262-012-0011-z.

PMID:
23055348
31.

[Wegener's granulomatosis with oral mucosal involvement as first manifestation].

Candau A, Valenzuela B, Dean A, Alamillos FJ.

Acta Otorrinolaringol Esp. 2014 Jan-Feb;65(1):53-5. doi: 10.1016/j.otorri.2012.03.008. Epub 2012 Jun 13. Spanish. No abstract available.

32.

[Population pharmacokinetics applied to optimising cisplatin doses in cancer patients].

Ramón-López A, Escudero-Ortiz V, Carbonell V, Pérez-Ruixo JJ, Valenzuela B.

Farm Hosp. 2012 Sep-Oct;36(5):392-402. doi: 10.1016/j.farma.2011.08.004. Epub 2012 Mar 7. Spanish.

PMID:
22402361
33.

An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain.

Ponsati B, Carreño C, Curto-Reyes V, Valenzuela B, Duart MJ, Van den Nest W, Cauli O, Beltran B, Fernandez J, Borsini F, Caprioli A, Di Serio S, Veretchy M, Baamonde A, Menendez L, Barros F, de la Pena P, Borges R, Felipo V, Planells-Cases R, Ferrer-Montiel A.

J Pharmacol Exp Ther. 2012 Jun;341(3):634-45. doi: 10.1124/jpet.111.190678. Epub 2012 Mar 5.

34.

[Populational pharmacokinetics of doxorubicin applied to personalised its dosing in cancer patients].

Escudero-Ortiz V, Ramón-López A, Duart MA, Pérez-Ruixo JJ, Valenzuela B.

Farm Hosp. 2012 Jul-Aug;36(4):282-91. Epub 2011 Nov 29. Spanish.

PMID:
22129650
35.

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs).

Martínez-Navarro EM, Rebollo J, González-Manzano R, Sureda M, Evgenyeva E, Valenzuela B, Fernández FJ, Forteza J, Brugarolas A.

Clin Transl Oncol. 2011 Nov;13(11):812-8. doi: 10.1007/s12094-011-0739-1.

PMID:
22082647
36.

[Population pharmacokinetics of gemcitabine applied to personalize the dosage used in cancer patients].

Ramón-López A, Escudero-Ortiz V, Duart-Duart MJ, Pérez-Ruixo JJ, Valenzuela B.

Farm Hosp. 2012 Jul-Aug;36(4):194-206. Epub 2011 Nov 10. Spanish.

PMID:
22078546
37.

Topological Fermi liquids from Coulomb interactions in the doped honeycomb lattice.

Castro EV, Grushin AG, Valenzuela B, Vozmediano MA, Cortijo A, de Juan F.

Phys Rev Lett. 2011 Sep 2;107(10):106402. Epub 2011 Sep 2.

PMID:
21981516
38.

Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Farias RV, Vargas DA, Castillo AE, Valenzuela B, Coté ML, Roth MJ, Leon O.

Antimicrob Agents Chemother. 2011 Oct;55(10):4735-41. doi: 10.1128/AAC.00658-11. Epub 2011 Jul 18.

39.

Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.

Valenzuela B, Rebollo J, Pérez T, Brugarolas A, Pérez-Ruixo JJ.

Br J Clin Pharmacol. 2011 Dec;72(6):978-81. doi: 10.1111/j.1365-2125.2011.04052.x. No abstract available.

40.

Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients.

Pérez-Ruixo C, Valenzuela B, Fernández Teruel C, González-Sales M, Miguel-Lillo B, Soto-Matos A, Pérez-Ruixo JJ.

Cancer Chemother Pharmacol. 2012 Jan;69(1):15-24. doi: 10.1007/s00280-011-1644-6. Epub 2011 May 18.

PMID:
21590449
41.

Conductivity anisotropy in the antiferromagnetic state of iron pnictides.

Valenzuela B, Bascones E, Calderón MJ.

Phys Rev Lett. 2010 Nov 12;105(20):207202. Epub 2010 Nov 9.

PMID:
21231260
42.

Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis.

Valenzuela B, Nalda-Molina R, Bretcha-Boix P, Escudero-Ortíz V, Duart MJ, Carbonell V, Sureda M, Rebollo JP, Farré J, Brugarolas A, Pérez-Ruixo JJ.

AAPS J. 2011 Mar;13(1):72-82. doi: 10.1208/s12248-010-9249-2. Epub 2011 Jan 6. Erratum in: AAPS J. 2011 Jun;13(2):318.

43.

[Strategies for dealing with cholera disease. A public health perspective of the Chilean experience].

Valenzuela B T, Salinas P H, Cárcamo I M, Cerda L J, Valdivia C G.

Rev Chilena Infectol. 2010 Oct;27(5):407-10. Spanish.

PMID:
21186505
44.

Low magnetization and anisotropy in the antiferromagnetic state of undoped iron pnictides.

Bascones E, Calderón MJ, Valenzuela B.

Phys Rev Lett. 2010 Jun 4;104(22):227201. Epub 2010 Jun 1.

PMID:
20867201
45.

[23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010].

Ripoll M E, Valenzuela B MT, Vergara F R, Abarca V K, Muñoz M A, Jiménez de la Jara J, Pinto C ME, Luchsinger F V.

Rev Chilena Infectol. 2010 Apr;27(2):133-7. doi: /S0716-10182010000200005. Epub 2010 May 13. Spanish.

46.

Surveillance system for infectious diseases of pets, Santiago, Chile.

López J, Abarca K, Cerda J, Valenzuela B, Lorca L, Olea A, Aguilera X.

Emerg Infect Dis. 2009 Oct;15(10):1674-6. doi: 10.3201/eid1510.081596.

47.

[Psychosocial factors associated with domestic water consumption in a semidesert region].

Arreguín-Moreno RH, Román-Pérez R, Laborín-Alvarez JF, Moreno JL, Valdez EA, Valenzuela B.

Salud Publica Mex. 2009 Jul-Aug;51(4):321-6. Spanish.

48.

Semi-mechanistic model for neutropenia after high dose of chemotherapy in breast cancer patients.

Ramon-Lopez A, Nalda-Molina R, Valenzuela B, Perez-Ruixo JJ.

Pharm Res. 2009 Aug;26(8):1952-62. doi: 10.1007/s11095-009-9910-6. Epub 2009 Jun 2.

PMID:
19488837
49.

[Climate change and infectious diseases. A novel epidemiological scenario].

Cerda L J, Valdivia C G, Valenzuela B MT, Venegas L J.

Rev Chilena Infectol. 2008 Dec;25(6):447-52. doi: /S0716-10182008000600006. Epub 2009 Jan 29. Spanish.

50.

[Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].

Abarca V K, Valenzuela B MT, Vergara F R, Luchsinger F V, Muñoz M A, Jiménez de la Jara J, Ripoll M E, O'Ryan G M.

Rev Chilena Infectol. 2008 Dec;25(6):428-34. doi: /S0716-10182008000600002. Epub 2009 Jan 29. Review. Spanish.

Supplemental Content

Loading ...
Support Center